The Latest in HCV Hub

Simulation model projects HCV to be rare by 2026

August 4, 2014

Interferon-free regimens yield 96%-100% SVRs

August 1, 2014

New HCV drugs could boost Part D spending by up to $5.8 billion

July 31, 2014

Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

July 24, 2014

Genotype 3 HCV linked to greater risk of cirrhosis, liver cancer

July 23, 2014

Everolimus fails to improve HCC survival

July 1, 2014

Medicare to cover hepatitis C screening

June 3, 2014